CANLI
Yükleniyor Veriler getiriliyor…
SCI-Expanded JCR Q4 Vaka Takdimi Scopus
Diagnosis of Immunoglobulin G4-related disease in a child with ligneous conjunctivitis: a novel mutation in plasminogen gene and plasminogen activator inhibitor-1 polymorphism
Ovid Technologies (Wolters Kluwer Health) 2023 Cilt 34
Scopus Eşleşmesi Bulundu
34
Cilt
456-461
Sayfa
Scopus Yazarları: Banu Bozkurt, Pınar Karabağlı, Melike Emiroglu, Halil Haldun Emiroğlu, M. Koplay, Nadir Koçak
Özet
ObjectivesLigneous conjunctivitis (LC) is a chronic conjunctivitis characterized by recurrent, firm, fibrin-rich, woody pseudomembranes on the palpebral conjunctiva. It is an ultrarare autosomal recessive disease associated with congenital plasminogen (PLG) deficiency due to mutations in the PLG gene (6q26). Immunoglobulin G4-related disease (IgG4-RD) is an idiopathic, systemic fibroinflammatory disease characterized by elevated serum IgG4 concentration and tissue infiltration of IgG4-positive plasma cells leading to organ enlargement, fibrosis and damage.Case ReportA 7-year-old girl with LC was hospitalized for recurrent pancreatitis and diagnosed as IgG4-RD. PLG activity level was 15% (normal range 55-145%). Co-segregation analysis indicated that the patient was homozygous for the c. NG_016200.1(NM_000301.5):c.1465 T>C mutation in PLG gene. c. NG_016200.1(NM_000301.5):c.1465 T>C PLG variant was found to be heterozygous by NGS analysis in both parents. She also had plasminogen activator inhibitor-1 (PAI-1) NG_013213.1(NM_000602.5):c.-816A>G (4G/4G) homozygous polymorphism and a heterozygote NG_001333.2 (NM_002769.5):c.292_293insC mutation in the serine protease 1 (PRSS-1) gene. However, heterozygous PRSS-1NG_001333.2 (NM_002769.5):c.292_293insC variant was found in the mother of the patient. All detected variants are currently considered as a variant of uncertain (or unknown) significance (VUS) according to the American College of Medical Genetics and Genomics (ACMG) classification. Oral steroid, oral azathioprine, topical fresh frozen plasma, topical heparin, topical steroid and topical cyclosporine were given. After 3years of follow-up, IgG4-RD is under partial remission and no pseudomembranes.ConclusionShe is the second case had both LC and IgG4-RD. We identified a NG_016200.1(NM_000301.5):c.1465 T>C novel homozygous mutation in PLG gene and a PAI-1 NG_016200.1(NM_000301.5):c.1465 T>C (4G/4G) homozygous polymorphism, which has been reported as a risk factor for thrombotic events.
Anahtar Kelimeler (Scopus)
homozygous mutation immunoglobulin G4-related disease ligneous conjunctivitis novel plasminogen gene

Anahtar Kelimeler

homozygous mutation immunoglobulin G4-related disease ligneous conjunctivitis novel plasminogen gene

Makale Bilgileri

Dergi Ovid Technologies (Wolters Kluwer Health)
ISSN 0957-5235
Yıl 2023 / 7. ay
Cilt / Sayı 34
Sayfalar 456 – 461
Makale Türü Vaka Takdimi
Hakemlik Hakemli
Endeks SCI-Expanded
JCR Quartile Q4
Yayın Dili Türkçe
Kapsam Uluslararası
Toplam Yazar 6 kişi
Erişim Türü Basılı+Elektronik
Erişim Linki Makaleye Git
Alan Sağlık Bilimleri Temel Alanı Çocuk İmmünolojisi ve Allerji Hastalıkları (Çocuk Sağlığı ve Hastalıkları)

YÖKSİS Yazar Kaydı

Yazar Adı EMİROĞLU MELİKE, BOZKURT BANU, EMİROĞLU HALİL HALDUN, KOPLAY MUSTAFA, KOÇAK NADİR, KARABAĞLI PINAR
YÖKSİS ID 7789516

Metrikler

JCR Quartile Q4
Yazar Sayısı 6